Pages that link to "Q35643631"
Jump to navigation
Jump to search
The following pages link to Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity (Q35643631):
Displaying 50 items.
- Multiple advantageous amino acid variants in the NAT2 gene in human populations (Q21144240) (← links)
- Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history (Q21283781) (← links)
- Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes (Q24540724) (← links)
- Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility (Q24679438) (← links)
- A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology. (Q24810267) (← links)
- Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome (Q24812002) (← links)
- Inferring haplotypes at the NAT2 locus: the computational approach (Q24815593) (← links)
- Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery (Q26995125) (← links)
- PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2 (Q27011622) (← links)
- N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk (Q28388128) (← links)
- Smoking, the xenobiotic pathway, and clubfoot (Q28672873) (← links)
- Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity (Q28744372) (← links)
- The Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and Metabolism (Q28822540) (← links)
- Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature. (Q30839905) (← links)
- Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment (Q31144283) (← links)
- Challenges identifying genetic determinants of pediatric cancers--the childhood leukemia experience (Q33236016) (← links)
- N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease (Q33237936) (← links)
- Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer (Q33608783) (← links)
- Interethnic diversity of NAT2 polymorphisms in Brazilian admixed populations. (Q33710997) (← links)
- Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses? (Q33770163) (← links)
- N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction (Q33985340) (← links)
- Caffeine, selected metabolic gene variants, and risk for neural tube defects (Q34051331) (← links)
- CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis (Q34568319) (← links)
- NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis (Q34606196) (← links)
- N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients (Q34944536) (← links)
- The role of N-acetyltransferase 2 polymorphism in the etiopathogenesis of inflammatory bowel disease (Q35038737) (← links)
- Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate (Q35049590) (← links)
- Crohn's disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene (Q35435673) (← links)
- Alcohol, Smoking, and Caffeine in Relation to Fecundability, with Effect Modification by NAT2 (Q35467782) (← links)
- Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes (Q35774965) (← links)
- Association between the N-acetylation genetic polymorphism and bronchial asthma (Q35804167) (← links)
- Glucuronidation and sulphation of paracetamol in HIV-positive patients and patients with AIDS. (Q36053659) (← links)
- Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2. (Q36158505) (← links)
- Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer (Q36408201) (← links)
- Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer (Q36410400) (← links)
- Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study (Q36447072) (← links)
- Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity (Q36747900) (← links)
- NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy (Q36809405) (← links)
- Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2 (Q36828813) (← links)
- Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients (Q37030180) (← links)
- Analysis association between mitochondrial genome instability and xenobiotic metabolizing genes in human breast cancer. (Q37126201) (← links)
- Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. (Q37221665) (← links)
- N-Acetyltransferase polymorphism and human cancer risk (Q37296621) (← links)
- Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients. (Q37411216) (← links)
- Distribution of arylamine N-acetyltransferase 2 (nat2) genotypes among Omanis (Q38478373) (← links)
- NAT2 genetic variations among South Indian populations (Q38893783) (← links)
- Cornerstones of Toxicology (Q39031264) (← links)
- Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population (Q39042848) (← links)
- Dapsone-induced agranulocytosis. The role of xenobiotic-metabolizing enzymes demonstrated by a case report (Q40504499) (← links)
- A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis. (Q41102009) (← links)